As far as SSc is concerned, our previous in vitro findings demonstrated a significant contribution of the neurovascular guidance molecules NRP1, Sema3E, and Slit2 in the dysregulation of the angiogenic process [9,18,20,21,22]. The gene discussed is SEMA3E; the disease is systemic sclerosis.